, Volume 188, Supplement 1, pp 13–17

Cough Due to Asthma and Nonasthmatic Eosinophilic Bronchitis



Asthma and nonasthmatic eosinophilic bronchitis are among the most common causes of chronic cough, accounting for about 25 and 10% of cases, respectively. Chronic cough due to asthma may present in isolation in which case it is known as cough-variant asthma. Nonasthmatic eosinophilic bronchitis is characterized by the presence of eosinophilic airway inflammation in the absence of variable airflow obstruction or airway hyperresponsiveness. Both conditions share many immunopathological features with the exceptions to date of mast cell infiltration into the airway smooth muscle, increased IL-13 expression, and narrowing and thickening of the airway wall, which are features reserved to asthma. In most cases the trigger that causes the cough is uncertain. However, removal of potential triggers is important to consider, in particular with respect to occupational exposure to known sensitisers. In both conditions there is subjective and objective improvement following treatment with inhaled corticosteroids, which is associated with the presence of an airway eosinophilia. Whether eosinophilic inflammation is the cause of cough or an epiphenomenon is uncertain, but the failure of anti-IL-5 to modify cough in asthma has questioned a causal association. In asthma, β-agonist theophylline, leukotriene receptor antagonist, and oral corticosteroid therapy improve cough. In noneosinophilic bronchitis, some patients require oral corticosteroids but the benefit of other additional therapies is unknown. In general, response to therapy in both conditions is very good and the limited long-term data available suggest that both usually have a benign course, although in some cases persistent airflow obstruction may occur.


Asthma Nonasthmatic eosinophilic bronchitis Chronic cough Mast cells IL-13 IL-5 


  1. 1.
    Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID (1999) Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 160:406–410PubMedGoogle Scholar
  2. 2.
    Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley MJ (1997) A systematic evaluation of mechanisms in chronic cough. Am J Respir Crit Care Med 156:211–216PubMedGoogle Scholar
  3. 3.
    Ayik SO, Basoglu OK, Erdinc M, Bor S, Veral A, Bílgen C (2003) Eosinophilic bronchitis as a cause of chronic cough. Respir Med 97:695–701CrossRefPubMedGoogle Scholar
  4. 4.
    Irwin RS, Corrao WM, Pratter MR (1981) Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 123:413–417PubMedGoogle Scholar
  5. 5.
    Irwin RS, Curley FJ, French CL (1990) Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 141:640–647PubMedGoogle Scholar
  6. 6.
    McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, Shepherd DR, MacMahon J (1998) Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 53:738–743CrossRefPubMedGoogle Scholar
  7. 7.
    Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE (1989) Chronic cough: eosinophilic bronchitis without asthma. Lancet 1:1346–1348CrossRefPubMedGoogle Scholar
  8. 8.
    Corrao WM, Braman SS, Irwin RS (1979) Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 300(12):633–637PubMedCrossRefGoogle Scholar
  9. 9.
    Belda J, Leigh R, Parameswaran K, O’Byrne PM, Sears MR, Hargreave FE (2000) Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 161:475–478PubMedGoogle Scholar
  10. 10.
    Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, Berman L, Dolovich J, Hargreave FE (1998) Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 158:1511–1517PubMedGoogle Scholar
  11. 11.
    Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ (1999) Non-eosinophilic corticosteroid unresponsive asthma. Lancet 353:2213–2214CrossRefPubMedGoogle Scholar
  12. 12.
    Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE (2000) A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 106:638–644CrossRefPubMedGoogle Scholar
  13. 13.
    Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID (2003) Comparison of the immunopathology of eosinophilic bronchitis and asthma. Thorax 58:528–532CrossRefPubMedGoogle Scholar
  14. 14.
    Lemiere C, Efthimiadis A, Hargreave FE (1997) Occupational eosinophilic bronchitis without asthma: an unknown occupational airway disease. J Allergy Clin Immunol 100:852–853CrossRefPubMedGoogle Scholar
  15. 15.
    Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, Pavord ID (2000) Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 162:878–882PubMedGoogle Scholar
  16. 16.
    Gibson PG, Zlatic K, Scott J, Sewell W, Woolley K, Saltos N (1998) Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 101:320–326CrossRefPubMedGoogle Scholar
  17. 17.
    Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID (2002) Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346:1699–1705CrossRefPubMedGoogle Scholar
  18. 18.
    Siddiqui S, Mistry V, Doe C, Roach K, Morgan A, Wardlaw A, Pavord I, Bradding P, Brightling C (2008) Airway hyperresponsiveness is dissociated from airway wall structural remodelling J Allergy Clin Immunol 122(2):335–341, 341.e1–3Google Scholar
  19. 19.
    Saha SK, Berry MA, Parker D, Siddiqui S, Morgan A, May R, Monk P, Bradding P, Wardlaw AJ, Pavord ID, Brightling CE (2008) Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol 121(3):685–691CrossRefPubMedGoogle Scholar
  20. 20.
    Siddiqui S, Cruse G, McKenna S, Monteiro W, Mistry V, Wardlaw A, Brightling C (2009) IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis. BMC Pulm Med 9:34CrossRefPubMedGoogle Scholar
  21. 21.
    Berry MA, Parker D, Neale N, Woodman L, Morgan A, Monk P, Bradding P, Wardlaw AJ, Pavord ID, Brightling CE (2004) Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 114(5):1106–1109CrossRefPubMedGoogle Scholar
  22. 22.
    Park SW, Jangm HK, An MH, Min JW, Jang AS, Lee JH, Park CS (2005) Interleukin-13 and interleukin-5 in induced sputum and eosinophilic bronchitis: comparison with asthma. Chest 128(4):1921–1927CrossRefPubMedGoogle Scholar
  23. 23.
    Siddiqui S, Gupta S, Cruse G, Haldar P, Entwisle J, Mcdonald S, Whithers PJ, Hainsworth SV, Coxson HO, Brightling C (2009) Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis. Allergy 64(6):951–958CrossRefPubMedGoogle Scholar
  24. 24.
    Hancox RJ, Leigh R, Kelly MM, Hargreave FE (2001) Eosinophilic bronchitis. Lancet 358:1104CrossRefPubMedGoogle Scholar
  25. 25.
    Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, Wardlaw AJ, Pavord ID (2005) Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 35(5):598–601CrossRefPubMedGoogle Scholar
  26. 26.
    Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID (1999) Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J 14:1228–1230CrossRefPubMedGoogle Scholar
  27. 27.
    Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID (2000) Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 356:1480–1485CrossRefPubMedGoogle Scholar
  28. 28.
    Matsumoto H, Niimi A, Takemura M, Ueda T, Tabuena R, Yamaguchi M, Matsuoka H, Hirai T, Muro S, Ito Y, Mio T, Chin K, Nishiyama H, Mishima M (2006) Prognosis of cough variant asthma: a retrospective analysis. J Asthma 43(2):131–135CrossRefPubMedGoogle Scholar
  29. 29.
    Dicpinigaitis PV (2006) Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):75S–79SCrossRefPubMedGoogle Scholar
  30. 30.
    Pizzichini MM, Pizzichini E, Parameswaran K, Clelland L, Efthimiadis A, Dolovich J, Hargreave FE (1999) Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 6:323–330PubMedGoogle Scholar
  31. 31.
    Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J (1995) Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy 25:127–132CrossRefPubMedGoogle Scholar
  32. 32.
    Brightling CE, Ward R, Wardlaw AJ, Pavord ID (2000) Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J 15:682–686CrossRefPubMedGoogle Scholar
  33. 33.
    Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID (2009) Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 360(10):973–984CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Institute for Lung Health, Department of Infection, Inflammation and ImmunityUniversity of Leicester, Glenfield HospitalLeicesterUK

Personalised recommendations